Rep. Dingell oversight of CLIA
This article was originally published in The Gray Sheet
Executive Summary
Staffers from Rep. John Dingell's (D-Mich.) House Energy and Commerce oversight subcommittee plan to meet with Bruce Vladeck after he is confirmed as Health Care Financing Administration chief to discuss their concerns with implementation of the Clinical Laboratory Improvement Amendments of 1988. Concerns include FDA delays in reviewing quality control labeling and assigning complexity categorizations for tests and the slow pace of third-party accreditation by HCFA. Vladeck was nominated to lead HCFA on March 5 ("The Gray Sheet" March 8, p. 25).